Brokerages Set Walgreens Boots Alliance, Inc. (NASDAQ:WBA) PT at $13.27

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) have been assigned a consensus recommendation of “Reduce” from the fifteen brokerages that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $13.27.

A number of analysts have recently weighed in on WBA shares. TD Cowen cut their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Royal Bank of Canada increased their price target on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a “sector perform” rating in a research report on Wednesday, January 15th. UBS Group lifted their price objective on Walgreens Boots Alliance from $9.00 to $10.00 and gave the company a “neutral” rating in a research note on Thursday, October 17th. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an “in-line” rating in a research note on Monday, January 13th. Finally, Bank of America lifted their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a research report on Monday, January 13th.

Walgreens Boots Alliance Stock Performance

Shares of WBA opened at $11.74 on Tuesday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a 50-day moving average of $9.73 and a two-hundred day moving average of $9.86. The stock has a market cap of $10.15 billion, a P/E ratio of -1.15, a P/E/G ratio of 1.43 and a beta of 0.64. Walgreens Boots Alliance has a one year low of $8.08 and a one year high of $23.76.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm had revenue of $39.50 billion during the quarter, compared to the consensus estimate of $37.40 billion. During the same quarter in the previous year, the company posted $0.66 earnings per share. The company’s revenue was up 7.6% compared to the same quarter last year. As a group, research analysts predict that Walgreens Boots Alliance will post 1.59 EPS for the current year.

Institutional Trading of Walgreens Boots Alliance

Several institutional investors have recently modified their holdings of the stock. Brooklyn Investment Group raised its position in shares of Walgreens Boots Alliance by 21.1% during the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator’s stock worth $44,000 after purchasing an additional 830 shares during the last quarter. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares in the last quarter. Sequoia Financial Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 4.4% during the third quarter. Sequoia Financial Advisors LLC now owns 25,215 shares of the pharmacy operator’s stock valued at $226,000 after acquiring an additional 1,063 shares during the last quarter. Lincluden Management Ltd. raised its holdings in shares of Walgreens Boots Alliance by 0.4% during the third quarter. Lincluden Management Ltd. now owns 264,644 shares of the pharmacy operator’s stock valued at $2,371,000 after acquiring an additional 1,074 shares during the last quarter. Finally, CWA Asset Management Group LLC lifted its position in shares of Walgreens Boots Alliance by 9.2% in the fourth quarter. CWA Asset Management Group LLC now owns 12,893 shares of the pharmacy operator’s stock valued at $120,000 after acquiring an additional 1,084 shares in the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.